President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture of what the new president has in mind for the economy. Of course, there's plenty for the market to digest when it comes to his trade and immigration policies,

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

President Donald Trump has repeatedly vowed he wouldn't allow Medicaid to be cut, but House Republicans' bill to fund his agenda aims to cut hundreds of billions of dollars from the program that provides health care for poor, elderly and disabled Americans.

"While there's nothing unlawful per se about rushing to enact policy in the final days of ... Kennedy defended a decision by the Trump administration last month not to cover weight loss drugs in Medicare and Medicaid, scrapping a proposal touted by the ...

The administration plans to "eliminate funding that had been used to carry out non-statutory, wasteful and woke activities."

President Donald Trump is attempting to implement a plan to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad.

Senate Democrats and the Biden administration dropped plans to set drug price caps based on the amount paid in other high-income countries, during talks years ago to push through the law that empowered Medicare to negotiate down the cost of prescription medications.